ReviewInternational journal of molecular sciences2026
Lipid Transfer Protein Allergens: A Comprehensive Overview of Current Knowledge.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-specific lipid transfer proteins (nsLTPs) constitute a widely distributed family of plant allergens with substantial clinical relevance, particularly in food allergy. Their marked thermal and proteolytic stability enables them to provoke reactions ranging from mild local symptoms to severe anaphylaxis. This narrative review synthesises current knowledge on nsLTP allergens, focusing on their molecular characteristics, taxonomic distribution, exposure routes, and clinical impact. Major allergenic sources include fruits, nuts and seeds, vegetables and cereals, as well as various pollens. Across these sources, Pru p 3 has emerged as the central and most extensively studied allergen, frequently acting as the primary sensitiser and exhibiting broad cross-reactivity with homologous nsLTPs from diverse plant species. Despite growing evidence, significant knowledge gaps remain regarding sensitisation pathways, environmental modifiers, and phenotype stratification. Continued research is required to improve diagnostic precision and guide the development of targeted therapeutic strategies for patients with nsLTP-mediated allergy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.